KPRX
NASDAQ · Pharmaceuticals
Kiora Pharmaceuticals Inc
$2.04
-0.02 (-0.97%)
Open$2.03
Previous Close$2.06
Day High$2.07
Day Low$2.00
52W High$4.18
52W Low$1.76
Volume—
Avg Volume27.6K
Market Cap7.69M
P/E Ratio—
EPS$-2.05
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,338.2% upside
Current
$2.04
$2.04
Target
$29.34
$29.34
$16.75
$29.34 avg
$32.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.28M | 7.88M | 1.95M |
| Net Income | 3.20M | 1.59M | 336.4K |
| Profit Margin | 22.4% | 21.3% | 17.3% |
| EBITDA | 3.97M | 2.08M | 564.5K |
| Free Cash Flow | — | — | 437.5K |
| Rev Growth | +81.3% | +81.3% | -4.0% |
| Debt/Equity | — | — | 0.84 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |